Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

The engineered Immunoprotein enhance broad-spectrum disease resistance in solanaceous crops.

Yan Huang | Li Li | Lijing Wei | Xuemei Yang | Shuangyan Zeng | Ting Zhang | Yong Li | Xinlan Shen | Zhouqing He | Jiuer Liu | Jinbo Shen | Yi Cai
BMC plant biology | 2026

The sustainability of global agricultural systems, a cornerstone for both economic security and food supply chains, is increasingly compromised by phytopathogen invasions. Herein, we characterize RP151—a novel biopesticide engineered through rational concatenation of plant immunity-stimulating peptides. This recombinant protein demonstrates exceptional bioavailability in Solanaceous crops like tobacco and tomato, inducing multifaceted defense responses within 24 h post-application, as evidenced by ROS burst, MAPK cascade activation, and localized callose deposition. Mechanistic studies reveal that RP151-mediated resistance against TMV and its co-infection with CMV primarily operates through SA-dependent signaling. ‌In comparative trials, RP151 significantly prolonged SAR duration and effectively suppressed lesion expansion in TMV-challenged plants relative to conventional antiviral agents. Notably, the broad-spectrum efficacy of RP151 was further validated against necrotrophic fungi (Botrytis cinerea) in tomato. RP151’s deployment could lead to a substantial reduction in the use of harmful pesticides, offering a sustainable, safe solution for enhancing plant defense against a variety of pathogens.

Pubmed ID: 41652542

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: General Project of Sichuan Natural Science Foundation,
    Id: 2024NSFSC0345
  • Agency: The National Innovation Training Project of China,
    Id: S202510626070
  • Agency: Chengdu Science and Technology Bureau,
    Id: 2020-RC02-00060-CG

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


NCBI (tool)

RRID:SCR_006472

A portal to biomedical and genomic information. NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information for the better understanding of molecular processes affecting human health and disease.

View all literature mentions